Telo Genomics Corp. (TDSGF)
USD 0.06
(-0.34%)
USD 0.06
(-0.34%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.05 CAD | -30.28% |
| 2022 | -0.04 CAD | -57.89% |
| 2021 | -0.02 CAD | 45.06% |
| 2020 | -0.04 CAD | 48.89% |
| 2019 | -0.08 CAD | -3.44% |
| 2018 | -0.08 CAD | 62.62% |
| 2017 | -0.21 CAD | -1220.75% |
| 2016 | -0.02 CAD | 38.37% |
| 2015 | -0.03 CAD | -193.18% |
| 2014 | -0.01 CAD | 70.67% |
| 2013 | -0.03 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.01 CAD | 14.53% |
| 2024 Q1 | -0.01 CAD | 21.67% |
| 2024 Q2 | -0.01 CAD | -24.47% |
| 2023 Q1 | -0.01 CAD | 5.45% |
| 2023 FY | - CAD | -30.28% |
| 2023 Q2 | -0.01 CAD | -3.85% |
| 2023 Q3 | -0.01 CAD | -10.19% |
| 2023 Q4 | -0.01 CAD | -0.84% |
| 2022 Q2 | -0.01 CAD | 5.95% |
| 2022 Q1 | -0.01 CAD | -33.33% |
| 2022 FY | - CAD | -57.89% |
| 2022 Q4 | -0.01 CAD | -26.44% |
| 2022 Q3 | -0.01 CAD | -10.13% |
| 2021 FY | - CAD | 45.06% |
| 2021 Q3 | -0.01 CAD | 4.62% |
| 2021 Q2 | -0.01 CAD | -96.97% |
| 2021 Q1 | -0.00 CAD | 59.26% |
| 2021 Q4 | -0.01 CAD | -1.61% |
| 2020 FY | - CAD | 48.89% |
| 2020 Q1 | -0.01 CAD | 32.47% |
| 2020 Q2 | -0.02 CAD | -123.08% |
| 2020 Q3 | -0.01 CAD | 66.38% |
| 2020 Q4 | -0.01 CAD | -3.85% |
| 2019 Q2 | -0.00 CAD | 70.79% |
| 2019 FY | - CAD | -3.44% |
| 2019 Q4 | -0.02 CAD | -79.07% |
| 2019 Q3 | -0.01 CAD | -230.77% |
| 2019 Q1 | -0.01 CAD | 90.09% |
| 2018 Q2 | -0.03 CAD | -34.5% |
| 2018 FY | - CAD | 62.62% |
| 2018 Q4 | -0.09 CAD | -519.31% |
| 2018 Q3 | -0.01 CAD | 46.1% |
| 2018 Q1 | -0.02 CAD | 91.3% |
| 2017 FY | - CAD | -1220.75% |
| 2017 Q3 | -0.04 CAD | -21.6% |
| 2017 Q1 | -0.11 CAD | -3337.5% |
| 2017 Q2 | -0.03 CAD | 69.27% |
| 2017 Q4 | -0.23 CAD | -459.61% |
| 2016 Q3 | -0.01 CAD | 35.61% |
| 2016 Q2 | -0.01 CAD | -1750.0% |
| 2016 Q1 | 0.00 CAD | 147.06% |
| 2016 FY | - CAD | 38.37% |
| 2016 Q4 | -0.00 CAD | 62.35% |
| 2015 FY | - CAD | -193.18% |
| 2015 Q4 | -0.00 CAD | -30.77% |
| 2015 Q3 | -0.00 CAD | 0.0% |
| 2015 Q2 | - CAD | 100.0% |
| 2015 Q1 | -0.00 CAD | 58.73% |
| 2014 FY | - CAD | 70.67% |
| 2014 Q1 | -0.00 CAD | 79.17% |
| 2014 Q2 | - CAD | 100.0% |
| 2014 Q3 | -0.01 CAD | 0.0% |
| 2014 Q4 | -0.01 CAD | 51.54% |
| 2013 Q2 | - CAD | 100.0% |
| 2013 Q4 | -0.00 CAD | -84.62% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | -0.00 CAD | 0.0% |
| 2013 Q1 | -0.00 CAD | 48.15% |
| 2012 Q4 | -0.00 CAD | 90.85% |
| 2012 Q3 | -0.03 CAD | 0.0% |